Relative abuse liability of triazolam: Experimental assessment in animals and humans

@article{Griffiths1985RelativeAL,
  title={Relative abuse liability of triazolam: Experimental assessment in animals and humans},
  author={Roland R. Griffiths and Richard J Lamb and Nancy A. Ator and John D Roache and Joseph V. Brady},
  journal={Neuroscience \& Biobehavioral Reviews},
  year={1985},
  volume={9},
  pages={133-151}
}

Figures from this paper

Abuse liability of triazolam: experimental measurements in animals and humans.

Drug abuse liability refers to: (a) the liability for abuse (i.e., the likelihood that a drug will be abused) and/or (b) the liability of abuse (i.e., the untoward effects of abusing the drug). These

Relative Abuse Liability of GHB in Humans: A Comparison of Psychomotor, Subjective, and Cognitive Effects of Supratherapeutic Doses of Triazolam, Pentobarbital, and GHB

TLDR
The profile of effects of GHB only partially overlaps with that of triazolam and pentobarbital, and the possibility of accidental overdose with GHB appears to be greater than with other sedative/hypnotic drugs.

Relative Abuse Liability of Indiplon and Triazolam in Humans: A Comparison of Psychomotor, Subjective, and Cognitive Effects

TLDR
The data suggest that although the abuse potential of indiplon is not different from that of triazolam at these doses, psychomotor and cognitive impairment after large doses ofIndiplon might be less.

Abuse Liability of Benzodiazepines: A Review of Human Studies Evaluating Subjective and/or Reinforcing Effects

This chapter reviews human experiments pertinent to the abuse liability of benzodiazepines. These studies assess subjective and/or reinforcing effects in subjects with histories of drug abuse (Table

Benzodiazepine self-administration in humans and laboratory animals – implications for problems of long-term use and abuse

TLDR
A current review of various problems that have been identified with the long-term use and the recreational abuse of benzodiazepines, including memory impairment, risk of accidents, falls and hip fractures in the elderly, a withdrawal syndrome, brain damage, overuse inThe elderly, over use by chronic pain patients, overused by alcoholics and recreational abuse among alcoholic and polydrug abusers are provided.

Behavioral Pharmacology of Zolpidem Relative to Benzodiazepines A Review

  • C. Rush
  • Psychology, Biology
    Pharmacology Biochemistry and Behavior
  • 1998

Clinical Pharmacokinetics of Non-Opiate Abused Drugs

TLDR
The clinical significance of kinetic characteristics with respect to abuse is discussed where possible and the pharmacokinetic properties that presumably contribute to self-administration and drug abuse include rapid delivery of the drug into the central nervous system and high free drug clearance.

Principles of drug abuse liability assessment in laboratory animals.

Pharmacokinetic considerations in abuse liability evaluation.

TLDR
Variations in drug metabolism may be related to dose-dependent kinetics, first-pass metabolism, and variations in genetic traits (e.g. poor or extensive metabolizers).
...

References

SHOWING 1-10 OF 140 REFERENCES

Abuse Liability of Benzodiazepines: A Review of Human Studies Evaluating Subjective and/or Reinforcing Effects

This chapter reviews human experiments pertinent to the abuse liability of benzodiazepines. These studies assess subjective and/or reinforcing effects in subjects with histories of drug abuse (Table

Differential effects of diazepam and pentobarbital on mood and behavior.

TLDR
The diazepam-produced deterioration in mood and social behavior was a subtle effect observed in a population for which usual therapeutic indications were lacking and at higher than usual therapeutic doses, and warrants clinical awareness in monitoring the course of treatment.

Dependence liability of several sedative-hypnotic agents evaluated in monkeys.

TLDR
Dependence liability of 10 drugs was tested in rhesus monkeys and benzoctamine and perlapine were found to be dependence-free drugs.

Comparison of diazepam and oxazepam: preference, liking and extent of abuse.

TLDR
Previous experimental observations suggesting that diazepam has a higher abuse liability than oxazepam are extended, compatible with an analysis of epidemiological data showing thatdiazepam abuse uniformly exceeds oxzepam abuse on seven epidemiological measures of drug abuse.

Reinforcing properties of stereoisomers of the putative sigma agonists N-allylnormetazocine and cyclazocine in rhesus monkeys.

  • B. SliferR. Balster
  • Biology, Psychology
    The Journal of pharmacology and experimental therapeutics
  • 1983
TLDR
Reinforcing doses of the three compounds resulted in injections evenly distributed across the 60-min session in a pattern similar to cocaine self-administration, whereas the racemic mixtures and the (-)-isomers produced negatively accelerated patterns of injections which resembled typical saline patterns of extinction responding.

Benzodiazepines on trial.

  • P. Tyrer
  • Psychology, Medicine
    British medical journal
  • 1984
TLDR
Ashton's careful study is the latest of several investigations that have shown quite unequivocally that benzodiazepines may produce pharmacological dependence in therapeutic dosage, and stems from the early symptoms of withdrawal being those of anxiety, so that when a patient becomes anxious after withdrawal of benzdiazepines this may be mistaken simply for a return of pre-existing anxiety.

Opioids: Similarity between evaluations of subjective effects and animal self‐administration results

TLDR
Good concordance between the human and animal results further validates each procedure and suggests the possibility that both thehuman and animal procedures are measuring a common underlying pharmacological property which relates to abuse potential of drugs.

Demonstration of tolerance to and physical dependence of N-allylnormorphine (nalorphine).

TLDR
The studies provide additional support for the hypothesis that the narcotic antagonists produce a type of physical dependence that is qualitatively different from that produced by the narcotics analgesics.

Pharmacology and Hypnotic Efficacy of Triazolam

TLDR
Overall, triazolam is an effective and safe compound for the symptomatic treatment of insomnia complaints, making it the shortest acting benzodiazepine available in the United States.
...